<DOC>
	<DOCNO>NCT00606320</DOCNO>
	<brief_summary>To assess safety efficacy long-term administration aripiprazole perform extended administration aripiprazole combination mood stabilizer ( lithium valproate ) unblinded manner patient complete precede multicenter , double-blind , placebo-controlled , parallel group-comparison trial aripiprazole patient bipolar disorder experience manic mixed episode ( Study 031-06-003 , hereafter `` Study 003 '' ) whose condition worsen remain unchanged discontinue Study 003 Day 14 Day 21 due lack drug efficacy .</brief_summary>
	<brief_title>A Multicenter , Investigative Study Safety Efficacy Extended Administration Aripiprazole Combination With Mood Stabilizer Treatment Patients With Bipolar Disorder Experiencing Manic Mixed Episode</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Trial subject men woman age 18 age 65 turn 65 trial . Subjects ability understand provide inform consent examination , observation , evaluation process specify protocol , sign informed consent form base full understanding trial . Subjects meet DSMIVTR criterion manic mixed episode diagnose `` 296.4x Bipolar I Disorder recent episode manic '' `` 296.6x Bipolar I Disorder recent episode mixed '' Subjects enrol complete withdrawn Study 003 meet follow criterion Subjects show exacerbation condition change condition : Those subject complete Study 003 , whose score CGIBP Change precede phase ( mania ) Day 21 ( completion Study 003 ) 5 ( Minimally bad ) 7 ( Very much bad ) ( subject show exacerbation condition ) , whose score 4 ( No change ) ( subject show change condition ) Subjects discontinue due lack drug efficacy : Those subject discontinue Study 003 Day 14 Day 21 , reason withdrawal lack drug efficacy , whose score CGIBP Change precede phase ( mania ) 5 ( Minimally bad ) 7 ( Very much bad ) Subjects present clinical picture and/or history consistent DSMIVTR diagnosis : Delirium , dementia , amnestic disorder , cognitive disorder Schizophrenia psychotic disorder Personality disorder Subjects psychotic symptom clearly due another general medical condition direct physiological effect substance Subjects represent significant risk commit suicide Subjects know complication allergy aripiprazole , quinolinoneskeleton compound , lithium , valproate Subjects complication neuroleptic malignant syndrome Subjects state physical exhaustion accompany condition dehydration malnutrition Subjects complication paralytic ileus Subjects complication organic brain disorder convulsive disorder , epilepsy Subjects complication diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>